WPRIM Management System> DCMS> Chinese Journal of Laboratory Medicine> 2022> 45> 10

Volume: 45 Issue: 10

1. Create a disease centered closed-loop coagulation test solution Page:997—999
2. Hematological malignancies immunotherapy-related coagulopathy and laboratory tests Page:1000—1004
3. The research progress of tissue factor pathway inhibitor Page:1005—1009
4. Current status and development trend of coagulation factor Ⅷ activity Page:1010—1016
5. Multicenter post-marketing clinical evaluation on the clinical performance of the five domestic fast nucleic acid detection reagents for 2019-nCoV Page:1045—1048
6. Value of hemagglutination indicators in the diagnosis of osteoporosis in patients with spinal degenerative diseases Page:1049—1055
7. Explore solutions to the "grey zone" of activated partial thromboplastin time mixing study Page:1056—1062
8. Plasma thrombin-antithrombin complex evaluates hypercoagulable states and predicts revasenosis after revascularization in patients of atherosclerosis obliterans Page:1063—1069
9. Clinical significance of plasma thrombin-antithrombin complex levels in patients with sepsis-induced cardiomyopathy Page:1070—1075
10. Analysis of laboratory parameters and death risk in patients with thrombotic thrombocytopenic purpura Page:1076—1082
11. Establishment and validation of reference interval of D-dimer in plasma of healthy pregnant women in Xi ′an Page:1083—1086
12. Establishment of a direct detection method for serum M-proteins without antibody enrichment based on MALDI-TOF MS technology Page:1087—1092
13. Research progress of extracellular vesicle metabolomics in tumor Page:1093—1098